Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer
Clinical trial NCT02115152 · UNKNOWN
Trial details
- NCT number
- NCT02115152
- Sponsor
- Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.